4 Largecap Revenue Growth 10-20 Per Cent Stocks to Watch for Future Multibagger Potential: Nestle India, Divi’s Labs, Cummins India and Apollo Hospitals
- October 28, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Nestle India Rs 1,180.50. Divi’s Labs Rs 9,505.50. Cummins India Rs 4,532. Apollo Hospitals Rs 7,791.50. Market caps from Rs 1.17 lakh crore to Rs 2.65 lakh crore. Data as of 27 Oct 2026.
Quick Answer
Nestle India, Divi’s Labs, Cummins India and Apollo Hospitals are the 4 picks in this revenue growth 10-20 per cent stocks watchlist, with market caps between Rs 1.17 lakh crore and Rs 2.65 lakh crore. Nestle India stands out for the highest return on equity at 67.85%, while Divi’s Labs offers the strongest latest-quarter profit growth at 65.50%. PE ratios run from 53.82 to 85.13, so compare each one with its industry PE before investing. All figures are as of 27 October 2026.
Revenue growth 10-20 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Nestle India, Divi’s Labs, Cummins India and Apollo Hospitals meet that test, with market caps from Rs 1.17 lakh crore to Rs 2.65 lakh crore and Nestle India offering the highest return on equity at 67.85%. Each of these companies has FY26 revenue growth between 10 and 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with FY26 revenue growth between 10 and 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening revenue growth 10-20 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 27 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Revenue Growth 10-20 Per Cent Stocks and Why Do They Attract Multibagger Interest?
Revenue growth 10-20 per cent stocks are shares of large companies whose sales grew by 10 to 20 per cent in FY26, a pace that is fast enough to build value and steady enough to sustain. The four here cover packaged foods, pharmaceutical ingredients, engines and hospitals.
Sales growth in this range shows steady demand for a company products, and it gives profit a solid base to grow from. For revenue growth 10-20 per cent stocks, both FY26 and the latest quarter showed growth. Investors researching revenue growth 10-20 per cent stocks get a fuller picture by reading growth and valuation together. The table below lines up revenue growth 10-20 per cent stocks on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use revenue growth 10-20 per cent stocks as a starting point for your own research.
Revenue Growth 10-20 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 27 October 2026. Apollo Hospitals has the lowest PE of the group at 53.82, while Nestle India posts the highest return on equity at 67.85%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Nestle India | 1,180.50 | 2,64,799 | 69.50 | 34.68 | 67.85% | 0.09 | 1,159.40 to 1,553.00 |
| Divi’s Laboratories | 9,505.50 | 2,48,979 | 85.13 | 36.42 | 15.32% | 0.00 | 5,647.50 to 9,740.00 |
| Cummins India | 4,532 | 1,36,044 | 57.47 | 45.93 | 27.87% | 0.00 | 3,883.10 to 6,100.00 |
| Apollo Hospitals Enterprise | 7,791.50 | 1,16,907 | 53.82 | 60.75 | 20.48% | 0.90 | 6,696.50 to 9,070.50 |
Nestle India: Return on Equity of 67.85%
Nestle India makes Maggi, KitKat, Nescafe and other packaged foods and beverages. It reported FY26 revenue of Rs 23,194.95 crore, up 14.48% year on year, and net profit of Rs 3,499.08 crore, up 9.09%. Operating margin was 22.49% in FY26. The debt-to-equity ratio is 0.09, which keeps interest costs low.
In the September 2026 quarter, revenue rose 20.52% to Rs 6,808.60 crore and net profit grew 35.85% to Rs 1,009.61 crore. Foreign investors raised their holding from 9.82% in September 2025 to 11.69% in September 2026. The stock trades at a PE of 69.50 against an industry PE of 34.68, with a return on equity of 67.85%.
Divi’s Labs: Debt-to-Equity of 0.00
Divi’s Laboratories makes active pharmaceutical ingredients and intermediates and runs a large custom synthesis business for global drug companies. It reported FY26 revenue of Rs 11,067 crore, up 13.95% year on year, and net profit of Rs 2,568 crore, up 17.21%. Revenue has compounded at 5.09% a year since FY22. Operating margin was 36.70% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
The stock trades at a PE of 85.13 against an industry PE of 36.42, with a return on equity of 15.32%. In the June 2026 quarter, revenue rose 24.32% to Rs 3,144 crore and net profit grew 65.50% to Rs 902 crore. The share price has gained 71.04% over five years and 38.43% over the past year. Foreign investors raised their holding from 19.39% in September 2025 to 20.38% in September 2026.
Cummins India: 26.11% Profit CAGR Since FY22
Cummins India makes engines and power generation equipment and exports a share of its output. It reported FY26 revenue of Rs 12,660.53 crore, up 16.82% year on year, and net profit of Rs 2,361.75 crore, up 18.09%. Net profit has compounded at 26.11% a year since FY22, while revenue has grown 18.53% a year. Operating margin was 27.15% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
In the June 2026 quarter, revenue rose 17.19% to Rs 3,563.35 crore and net profit grew 0.89% to Rs 609.30 crore. The share price has gained 408.59% over five years and 16.98% over the past year. Foreign investors raised their holding from 17.50% in June 2025 to 21.19% in June 2026. The stock trades at a PE of 57.47 against an industry PE of 45.93, with a return on equity of 27.87%.
Apollo Hospitals: Return on Equity of 20.48%
Apollo Hospitals Enterprise runs one of India’s largest hospital networks and also operates pharmacies and a digital health platform. It reported FY26 revenue of Rs 25,420.10 crore, up 15.58% year on year, and net profit of Rs 2,002.70 crore, up 33.06%. Net profit has compounded at 16.13% a year since FY22, while revenue has grown 14.59% a year. Operating margin was 15.80% in FY26.
The stock trades at a PE of 53.82 against an industry PE of 60.75, below the sector average, with a return on equity of 20.48%. In the June 2026 quarter, revenue rose 20.57% to Rs 7,092.30 crore and net profit grew 38.41% to Rs 610.40 crore. The share price has gained 83.08% over five years. Domestic institutions raised their holding from 21.12% in September 2025 to 22.07% in September 2026.
Revenue Growth 10-20 Per Cent Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these revenue growth 10-20 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | Latest Quarter Revenue Growth | Net Profit Growth (YoY) | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Nestle India | 23,194.95 | 3,499.08 | 14.48% | 20.52% | 9.09% | 23.81% |
| Divi’s Labs | 11,067 | 2,568 | 13.95% | 24.32% | 17.21% | 42.82% |
| Cummins India | 12,660.53 | 2,361.75 | 16.82% | 17.19% | 18.09% | 24.99% |
| Apollo Hospitals | 25,420.10 | 2,002.70 | 15.58% | 20.57% | 33.06% | 16.39% |
Check the Univest Screener for live data on these revenue growth 10-20 per cent stocks
Institutional Holding in Nestle India, Divi’s Labs, Cummins India and Apollo Hospitals
Institutional holding shows who is backing these revenue growth 10-20 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Apollo Hospitals has the deepest institutional backing, with FII and DII together holding 65.25% as of September 2026. Domestic institutions increased their holding over the past year in Apollo Hospitals (from 21.12% to 22.07%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Nestle India | 62.76% | 11.69% | 10.67% | 14.87% | September 2026 |
| Divi’s Labs | 51.88% | 20.38% | 19.17% | 8.58% | September 2026 |
| Cummins India | 51.00% | 21.19% | 19.16% | 8.66% | June 2026 |
| Apollo Hospitals | 28.02% | 43.18% | 22.07% | 6.72% | September 2026 |
Risks to Weigh in Revenue Growth 10-20 Per Cent Stocks
Being careful with revenue growth 10-20 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Divi’s Labs trades at a PE of 85.13 against an industry PE of 36.42, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Revenue Growth 10-20 Per Cent Stocks
Picking from revenue growth 10-20 per cent stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (34.68 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Nestle India, Divi’s Labs, Cummins India and Apollo Hospitals live prices.
Conclusion
Among revenue growth 10-20 per cent stocks, Nestle India stands out for the highest return on equity at 67.85%, Divi’s Labs for the strongest latest-quarter profit growth at 65.50%, Cummins India for the fastest profit growth, 26.11% a year since FY22 and Apollo Hospitals for the lowest PE of the group at 53.82. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing revenue growth 10-20 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Revenue Growth 10-20 Per Cent Stocks to Watch
Which are the best revenue growth 10-20 per cent stocks to watch for multibagger potential?
Ans. Nestle India, Divi’s Labs, Cummins India and Apollo Hospitals are the 4 names this list highlights, with market caps of Rs 2,64,799 crore, Rs 2,48,979 crore, Rs 1,36,044 crore and Rs 1,16,907 crore respectively. Nestle India is notable for the highest return on equity at 67.85%. Divi’s Labs stands out for the strongest latest-quarter profit growth at 65.50%. Cummins India offers the fastest profit growth, 26.11% a year since FY22. Apollo Hospitals brings the lowest PE of the group at 53.82. These are watchlist names for revenue growth 10-20 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Nestle India a good stock for long-term investors?
Ans. Nestle India has a return on equity of 67.85%, a PE of 69.50 against an industry PE of 34.68 and a market cap of Rs 2,64,799 crore. FY26 revenue rose 14.48%, and September 2026 quarter net profit grew 35.85%. Long-term returns in revenue growth 10-20 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Cummins India become a multibagger from here?
Ans. Cummins India has already gained 408.59% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in revenue growth 10-20 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 26.11% a year since FY22, and FY26 revenue rose 16.82%. At a PE of 57.47 against an industry PE of 45.93, valuation should be checked against that growth before investing.
What is the market cap of Nestle India, Divi’s Labs, Cummins India and Apollo Hospitals?
Ans. As of 27 October 2026, Nestle India has a market cap of Rs 2,64,799 crore, Divi’s Labs has a market cap of Rs 2,48,979 crore, Cummins India has a market cap of Rs 1,36,044 crore and Apollo Hospitals has a market cap of Rs 1,16,907 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on revenue growth 10-20 per cent stocks.
What are the risks of investing in revenue growth 10-20 per cent stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Divi’s Labs trades at a PE of 85.13 against an industry PE of 36.42, so earnings growth needs to hold up.
Why is Divi’s Labs trading at a PE of 85.13?
Ans. Divi’s Labs’ PE of 85.13 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 15.32% and latest-quarter profit growth of 65.50%, which also means the stock is more sensitive if growth slows. Investors in revenue growth 10-20 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Nestle India, Divi’s Labs, Cummins India and Apollo Hospitals?
Ans. As of the latest reported quarter, FII and DII together hold 22.36% of Nestle India (11.69% and 10.67%), 39.55% of Divi’s Labs (20.38% and 19.17%), 40.35% of Cummins India (21.19% and 19.16%) and 65.25% of Apollo Hospitals (43.18% and 22.07%). Rising institutional holding is a useful signal in revenue growth 10-20 per cent stocks, though it should be read with earnings trends rather than on its own.
